242 related articles for article (PubMed ID: 24119483)
21. Resource use and cost of hepatitis C-related care.
Nevens F; Colle I; Michielsen P; Robaeys G; Moreno C; Caekelbergh K; Lamotte M; Wyffels V
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1191-8. PubMed ID: 22836284
[TBL] [Abstract][Full Text] [Related]
22. Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments.
Sypsa V; Touloumi G; Papatheodoridis GV; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Koutsounas S; Hatzakis A
J Viral Hepat; 2005 Sep; 12(5):543-50. PubMed ID: 16108772
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).
Dore GJ; Ward J; Thursz M
J Viral Hepat; 2014 May; 21 Suppl 1():1-4. PubMed ID: 24713003
[TBL] [Abstract][Full Text] [Related]
24. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation.
Shiffman ML
Liver Transpl; 2003 Nov; 9(11):S14-20. PubMed ID: 14586890
[TBL] [Abstract][Full Text] [Related]
25. [Chronic hepatitis C].
Grammatikos G; Sarrazin C
Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
[TBL] [Abstract][Full Text] [Related]
26. Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma.
Mehta N; Yao FY
Liver Transpl; 2017 Dec; 23(12):1596-1600. PubMed ID: 29024442
[No Abstract] [Full Text] [Related]
27. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
Romani F; Belli LS; Rondinara GF; DeCarlis L; Rimoldi P; Riolo F; Bellati G; Ideo G; Belli L
J Am Coll Surg; 1994 Apr; 178(4):379-84. PubMed ID: 8149037
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C in haemophilia: lights and shadows.
Rumi MG; De Filippi F; Santagostino E; Colombo M
Haemophilia; 2004 Oct; 10 Suppl 4():211-5. PubMed ID: 15479400
[TBL] [Abstract][Full Text] [Related]
29. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study.
Wong WWL; Haines A; Bremner KE; Yao Z; Calzavara A; Mitsakakis N; Kwong JC; Sander B; Thein HH; Krahn MD
CMAJ Open; 2021; 9(1):E167-E174. PubMed ID: 33688024
[TBL] [Abstract][Full Text] [Related]
30. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
[TBL] [Abstract][Full Text] [Related]
31. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
32. Liver transplantation for viral hepatitis.
McCaughan GW; Koorey DJ; Strasser SI
Hosp Med; 2005 Jan; 66(1):8-12. PubMed ID: 15686159
[TBL] [Abstract][Full Text] [Related]
33. Management of chronic hepatitis C.
Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342
[TBL] [Abstract][Full Text] [Related]
34. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
[TBL] [Abstract][Full Text] [Related]
35. [Liver transplantation: personalized immunosuppression in patients with hepatitis C virus infection and hepatocellular carcinoma].
Rubín A; Berenguer M
Gastroenterol Hepatol; 2013 Jan; 36(1):48-57. PubMed ID: 22578313
[TBL] [Abstract][Full Text] [Related]
36. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
[TBL] [Abstract][Full Text] [Related]
37. Treating hepatitis C infection in liver transplant recipients.
Terrault NA; Berenguer M
Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944
[TBL] [Abstract][Full Text] [Related]
38. Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
Samri A; Roque-Afonso AM; Beran O; Tateo M; Teicher E; Feray C; Sebagh M; Guettier C; Dussaix E; Vittecoq D; Samuel D; Autran B; Duclos-Vallée JC
J Hepatol; 2009 Dec; 51(6):1000-9. PubMed ID: 19833404
[TBL] [Abstract][Full Text] [Related]
39. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
Yu L; Morishima C; Ioannou GN
Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
[TBL] [Abstract][Full Text] [Related]
40. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
Nishiguchi S; Kubo S; Shiomi S
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
